Deflazacort vs prednisone/prednisolone – A post hoc analysis from the ACT DMD trial

SOUTH PLAINFIELD, N.J., July 24, 2018 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the publication of data in Muscle & Nerve comparing the efficacy and safety of deflazacort and prednisone/prednisolone from the placebo arm of the ACT DMD study. The results demonstrated a clinically differentiated benefit of deflazacort… Att fortsätt läsa

Myotonic dystrophy type 1: Cognitive behavioural therapy for severe fatigue

Myotonic dystrophy type 1 is the most common form of muscular dystrophy in adults and leads to severe fatigue, substantial physical functional impairment, and restricted social participation. Lancet released this randomised study, whether cognitive behavioural therapy optionally combined with graded exercise compared with standard care alone improved the health status… Att fortsätt läsa

Fysioterapi og trening hos voksne med muskelsykdom

Muskelsvakhet er det som primært forbindes med muskelsykdom med ulik distribusjon i hver undergruppen. Man skiller ofte mellom proksimal og distal muskelsvakhet. I tillegg kan svekkelse av rygg- og magemuskulatur være betydelig ved enkelte diagnoser Smerter hos pasienter med arvelige muskelsykdommer er lite studert, men beskrives ofte av pasientene selv…. Att fortsätt läsa